Estonia, Sept. 15 -- Estonia based AS Oribalt Tallinn has secured contract from sihtasutus Pohja-Eesti Regionaalhaigla for Pharmaceutical Products - anti -tumor agents, endocrinological treatment, immunostimulators, immunosupers, diagnostic agents, all other therapeutic agents, other systemic haemostatic agents. The value of the contract is worth 16500000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....